The global DNA synthesizer market size was valued at USD 228.2 million in 2022, driven by the increasing demand for efficient DNA synthesizers across the globe. The market size is anticipated to grow at a CAGR of 14.4% during the forecast period of 2023-2031 to achieve a value of USD 767.1 million by 2031.
DNA synthesizers are devices that produce DNA molecules with a specific sequence of nucleotides. These molecules can be utilized to treat diseases by replacing damaged DNA with repaired sections. A DNA synthesizer is a crucial laboratory instrument used to chemically create or synthesize DNA molecules. It plays a vital role in molecular biology, genetics, and biotechnology research, as it enables scientists to design custom DNA sequences for different purposes, including cloning, gene expression studies, genetic engineering, and DNA sequencing.
The increasing demand for DNA synthesis technology is due to the widespread application in research to better understand the mechanisms of disease and in the drug discovery process to combat disease is a major trend influencing the market growth.
The continuous research and development activities by biotech firms and other institutions are also majorly contributing to the global DNA synthesizer market growth. For example, recently this year, Ansa Biotechnologies, Inc. claimed a successful creation of the world’s longest DNA oligonucleotide in a single synthesis. The 1005-base sequence codes for a key part of an adeno-associated virus vector used to develop gene therapy.
The market is experiencing heavy investments by synthetic biology companies that are interested in developing new technological advancements in this area, further expected to expand the market growth. For example, a UK-based synthetic biology company, Camena Bioscience, recently announced the closing of a USD 10 million Series A financing round, led by Mercia, a UK-based venture capital firm. Camena aims to scale operations and continue developing gSynth, its enzyme-based DNA synthesis platform.
Market Breakup by Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
The growth of the market is expected to be driven by the increasing demand for efficient DNA synthesizers from life science laboratories and pharmaceutical and biotechnology companies. Another key factor is the rapid developments in genomics and life sciences, boosting the market growth further. The increasing significance of DNA synthesizers in synthetic and molecular biology is also supporting the market growth. The market is also experiencing high demand for nucleic acid synthesis platforms among several end users, further propelling the global DNA synthesizer market growth.
The increasing technological advancements are also a key factor driving the global market. The proven efficacy of benchtop DNA synthesizers as they increase the speed and efficiency of research in academic and industrial labs is contributing to the increased demand in the market, further expected to boost the growth of the market in the coming years.
The efforts to lower the cost of synthesizing DNA oligonucleotides and commercialize scalable DNA synthesizers are continuously increasing. Significant progress has been made towards the goal of affordable DNA synthesis with microfluidic/microarray oligonucleotide synthesis methods and improvements in synthetic DNA quality.
Furthermore, ongoing advancements in other efficient synthesis technologies are also expected to make synthesizers widely available at lower costs, adding further value to the global DNA synthesizer market share.
North America is currently leading the global market and is expected to keep leading throughout the forecast period due to the presence of several key players in the market and their continuous developments. Moreover, the market is also driven by ongoing technological advancements, increased investment in research and development activities, and growing demand for innovative synthesizers.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type||
|Breakup by Application||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global DNA Synthesizer Market Overview
3.1 Global DNA Synthesizer Market Historical Value (2016-2022)
3.2 Global DNA Synthesizer Market Forecast Value (2023-2031)
4 Global DNA Synthesizer Market Landscape
4.1 DNA Synthesizer: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 DNA Synthesizer: Product Landscape
4.2.1 Analysis by Application
4.2.2 Analysis by Type
4.2.3 Analysis by End User
5 Global DNA Synthesizer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global DNA Synthesizer Market Segmentation
6.1 Global DNA Synthesizer Market by Type
6.1.1 Market Overview
6.1.2 Benchtop DNA Synthesizers
6.1.3 Large-scale DNA Synthesizers
6.2 Global DNA Synthesizer Market by Application
6.2.1 Market Overview
6.2.2 Research and Development
6.3 Global DNA Synthesizer Market by End User
6.3.1 Market Overview
6.3.2 Biopharmaceutical Companies
6.3.3 Academic and Research Institutes
6.3.4 Contract Research Organizations
6.4 Global DNA Synthesizer Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America DNA Synthesizer Market
7.1 Market Share by Country
7.2 United States of America
8 Europe DNA Synthesizer Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific DNA Synthesizer Market
9.1 Market Share by Country
10 Latin America DNA Synthesizer Market
10.1 Market Share by Country
11 Middle East and Africa DNA Synthesizer Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 LGC Biosearch Technologies
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Bioneer Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Thermo Fisher Scientific, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 IBA GmbH
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Twist Bioscience
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Eton Bioscience
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Quintara Biosciences
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Eurofins Scientific
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Integrated DNA Technologies, Inc
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Integrated DxNA Technologies, Inc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 228.2 million in 2022, driven by the increasing research and development activities.
The market is anticipated to grow at a CAGR of 14.4% during the forecast period of 2023-2031, likely to reach a market value of USD 767.1 million by 2031.
The rapidly advancing healthcare infrastructure, rising investment by the governments and leading organisations, and the increasing demand for innovative synthesizers are among the key factors driving the market growth.
The companies investing heavily in research activities for new developments in the segment is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The major types of synthesizers include benchtop DNA synthesizers and large-scale DNA synthesizers.
DNA synthesizers find wide applications in research and development, academic, industrial, diagnosis, therapeutics sector.
The end-users of the synthesizers include contract research organizations, biopharmaceutical companies, academic and research institutes.
Key players involved in the market are LGC Biosearch Technologies, Bioneer Corporation, Thermo Fisher Scientific, Inc., IBA GmbH, Twist Bioscience, Eton Bioscience, Quintara Biosciences, Integrated DNA Technologies, Inc, Integrated DxNA Technologies, Inc., and Eurofins Scientific.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.